Jonathan P. Mow
2020
In 2020, Jonathan P. Mow earned a total compensation of $1.8M as Chief Executive Officer at PhaseBio Pharmaceuticals, a 47% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $273,300 |
---|---|
Option Awards | $951,200 |
Salary | $529,317 |
Other | $9,819 |
Total | $1,763,636 |
Mow received $951.2K in option awards, accounting for 54% of the total pay in 2020.
Mow also received $273.3K in non-equity incentive plan, $529.3K in salary and $9.8K in other compensation.
Rankings
In 2020, Jonathan P. Mow's compensation ranked 6,098th out of 13,090 executives tracked by ExecPay. In other words, Mow earned more than 53.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,098 | 53rd |
Manufacturing | 2,517 | 55th |
Chemicals And Allied Products | 1,010 | 55th |
Drugs | 875 | 55th |
Pharmaceutical Preparations | 653 | 55th |
Mow's colleagues
We found two more compensation records of executives who worked with Jonathan P. Mow at PhaseBio Pharmaceuticals in 2020.